209 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Protozoan Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cryptosporidiosis and Enteropathogens in Bangladesh
Condition: Cryptosporidiosis
Intervention:
2 Unknown  Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
3 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
4 Not yet recruiting Severe and Cerebral Malaria Investigated Through Host Metabolomics
Condition: Severe Malaria
Intervention: Other: Observation
5 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
6 Unknown  Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
7 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
8 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
9 Recruiting Asymptomatic Leishmania Infection in HIV Patients
Condition: Visceral Leishmaniasis
Intervention:
10 Recruiting Controlled Human Malaria Infection Model for Evaluation of Transmission‐Blocking Interventions - Study 1
Condition: Malaria
Interventions: Drug: Sulfadoxine-pyrimethamine (low dose);   Drug: Piperaquine (low dose);   Drug: Sulfadoxine-pyrimethamine (high dose);   Drug: Piperaquine (high dose);   Biological: malaria challenge infection, P. falciparum 3D7;   Drug: Atovaquone-proguanil
11 Not yet recruiting Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Matched-Placebo for Tafenoquine;   Drug: Primaquine;   Drug: Matched-Placebo for Primaquine;   Drug: Dihydroartemisinin-piperaquine (DHA-PQP);   Drug: ACT plus PQ (Rescue medication);   Drug: PQ (End of study treatment)
12 Not yet recruiting Child Follow-up Until 2 Years
Conditions: Malaria;   Pregnancy
Intervention:
13 Not yet recruiting Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
Condition: Malaria
Interventions: Drug: Monthly Sulfadoxine-Pyrimethamine (SP) During Pregnancy;   Drug: Monthly Dihydroartemisinin-Piperaquine (DP) During Pregnancy
14 Not yet recruiting Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
Condition: Malaria
Intervention:
15 Recruiting Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers
Condition: Malaria
Interventions: Drug: Arterakine (DHA/piperaquine);   Drug: Placebo
16 Not yet recruiting A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)
Condition: Uncomplicated Malaria
Interventions: Drug: PQ supervised;   Drug: PQ unsupervised
17 Recruiting Plasmodium Immunotherapy for Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Biological: Blood-stage infection of P. vivax
18 Recruiting MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B
Condition: Malaria
Interventions: Drug: MMV390048 40mg;   Drug: MMV390048 dose to be determined mg
19 Recruiting Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A
Condition: Malaria
Interventions: Drug: MMV390048 40 mg;   Drug: Placebo to match MMV390048 40 mg;   Drug: MMV390048 80 mg;   Drug: Placebo to match MMV390048 80 mg;   Drug: MMV390048 120 mg;   Drug: Placebo to match MMV390048 120 mg
20 Not yet recruiting PfSPZ Challenge in Non-immune Adults in Baltimore, USA
Condition: Plasmodium Falciparum Infection
Interventions: Biological: PfSPZ (NF54);   Biological: PfSPZ (7G8)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years